A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to transjugular intrahepatic portosystemic shunt, or TIPS, according to a recently ...
Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosis Feedback from hepatology community supports US market potential from ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of ...
To the Editor: In the article, "Hemodynamics in the Cirrhotic Patient during Paracentesis." which appeared in the March 2 issue of the Journal, Knauer and Lowe report on circulatory changes occurring ...
Large-volume paracentesis is a treatment used to remove excess fluid in the abdominal cavity resulting from such conditions as cirrhosis of the liver or cardiac failure. It is normally performed as an ...
HERNIA is known to be more frequent among patients with cirrhosis of the liver, especially with ascites, than among those without liver disease. Chapman et al. 1 reported a rate of 10 per cent in 58 ...
HealthDay News— Aflibercept, a potent inhibitor of vascular endothelial growth factor (VEGF), shows clinical activity and increases the time to repeat paracentesis for patients with advanced ...
Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures, and ...
Background: A 63-year-old Caucasian woman presented with intermittent, left-sided abdominal discomfort without other symptoms. Physical examination revealed massive splenomegaly and complete blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback